Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAPE-NA1 trial of nerinetide in acute ischemic stroke undergoing endovascular thrombectomy
2016-001826-33Phase 3Completed
- Sponsor
- NoNO Inc.
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing Nerinetide with Placebo (2 arms). Primary endpoint: Primary efficacy outcome. Started May 2017; status: completed.
02
Drugs
nerinetide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2016-001826-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001826-33.